Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Oil closes at highest level since March on vaccine trials, Biden transition

11/24/2020 | 04:57pm EST
FILE PHOTO: The sun is seen behind a crude oil pump jack in the Permian Basin in Loving County

NEW YORK (Reuters) - Oil rose about 4% on Tuesday to touch highs not seen since March as a third promising coronavirus vaccine raised hope for fuel- demand recovery and U.S. President-elect Joe Biden began his transition to the White House.

Brent crude settled at $47.86 a barrel, gaining $1.80, or 3.9%. U.S. West Texas Intermediate crude settled at $44.91 a barrel, rising $1.85 or 4.3%.

Both benchmarks ended at their highest close since March 5.

AstraZeneca on Monday said its COVID-19 vaccine was 70% effective in trials and could be up to 90% effective, giving the fight against the pandemic another potential vaccine after positive results from Pfizer-BioNTech and Moderna.

However, the vaccine will not be readily available for several months, meaning people will likely restrict travel and other activities through next year to try to slow the spread of the disease.

"The petroleum complex is the vaccine trade," said John Kilduff, partner at Again Capital in New York. "Until we can see the other side of the pandemic, the market is going to be mired in slack demand that is going to keep the overhang extensive."

The coronavirus pandemic, coupled with the collapse of an OPEC-led output pact, sent prices crashing in March.

After the collapse of that output pact led to a brief Saudi Arabia-Russia price war, the Organization of the Petroleum Exporting Countries and allies agreed a new deal on record production cuts to support prices.

The group known as OPEC+ is expected to roll over those cuts into 2021 after meeting Nov. 30 to Dec. 1, following technical talks this week.

In addition, the administration of President Donald Trump, a Republican, gave the Democratic president-elect access to resources that will enable him to take over in January after delaying for weeks despite Trump's loss in the Nov. 3 election.

Biden's early selection of top advisers helped buoy crude futures and equities, which oil often follows.

Oil prices pared gains slightly in post-settlement trade after the American Petroleum Institute, an industry group, reported U.S. crude inventories rose by 3.8 million barrels in the week to Nov. 20 to about 490 million barrels, compared with analysts' expectations in a Reuters poll for a build of 127,000 barrels. [EIA/S]

Official U.S. government crude stocks data will be released on Wednesday.

(Reporting by Laila Kearney in New York; Additional reporting by Alex Lawler and Jessica Jaganathan in London; Editing by Cynthia Osterman and Matthew Lewis)

By Laila Kearney


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -1.56% 7657 Delayed Quote.6.21%
MODERNA, INC. 6.10% 165.1014 Delayed Quote.49.07%
PFIZER INC. 0.78% 36.1 Delayed Quote.-1.55%
All news about MODERNA, INC.
09:44aMARKET CHATTER : Moderna COVID-19 Vaccine Delivery Could Suffer Delays In Switze..
MT
08:31aASTRAZENECA : Vaccine factory inspected amid EU dispute with AstraZeneca
AQ
07:28aEXCLUSIVE : Pharma distributors in talks with U.S. for cut of COVID-19 vaccine s..
RE
06:03aRACING THE VIRUS : Why tweaking the vaccines won't be simple
RE
04:50aMODERNA : Answering the Call
AQ
01/27Pfizer Covid-19 Vaccine Works Against Mutations Found in U.K, South Africa Va..
DJ
01/27EU Clashes With AstraZeneca Over Covid-19 Vaccine Shortfall
DJ
01/2747.2 MLN DOSES OF COVID-19 VACCINES : U.s. cdc
RE
01/27EU health official blasts slow vaccine delivery, and is consulting with Canad..
AQ
01/27COVID SCIENCE-Drugs, vaccines less effective vs new virus variants; antibody ..
RE
More news
Financials (USD)
Sales 2020 512 M - -
Net income 2020 -571 M - -
Net cash 2020 2 597 M - -
P/E ratio 2020 -127x
Yield 2020 -
Capitalization 61 624 M 61 624 M -
EV / Sales 2020 115x
EV / Sales 2021 5,41x
Nbr of Employees 1 100
Free-Float 90,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 137,93 $
Last Close Price 155,73 $
Spread / Highest target 18,8%
Spread / Average Target -11,4%
Spread / Lowest Target -55,7%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.49.07%61 624
LONZA GROUP AG3.66%49 275
CELLTRION, INC.-10.58%40 532
IQVIA HOLDINGS INC.-3.44%33 169
SEAGEN INC.-7.11%29 430
HANGZHOU TIGERMED CONSULTING CO.,LTD18.50%22 468